Literature DB >> 6365308

Development of polycythemia vera and chronic lymphocytic leukemia during the course of refractory idiopathic thrombocytopenic purpura.

G Wang, Y S Ahn, C C Whitcomb, W J Harrington.   

Abstract

A case in which polycythemia vera and chronic lymphocytic leukemia (CLL) developed during the course of idiopathic thrombocytopenic purpura (ITP) is described. Observations in this case suggest that ITP was a pre-monitor of the clinical development of CLL and preceded the manifestation of polycythemia vera. The polycythemia was mild, requiring infrequent phlebotomies, and, as the CLL progressed, the requirement for phlebotomy diminished. Evidence of both CLL and myeloid proliferation, as well as severe immune thrombocytopenia, persisted throughout her course. Studies on lymphocytes revealed characteristics of those of CLL. Excellent therapeutic response of the CLL was observed with the use of vinblastine and steroids.

Entities:  

Mesh:

Year:  1984        PMID: 6365308     DOI: 10.1002/1097-0142(19840415)53:8<1770::aid-cncr2820530827>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

Authors:  Charles C Chu; Lu Zhang; Arjun Dhayalan; Briana M Agagnina; Amanda R Magli; Gia Fraher; Sebastien Didier; Linda P Johnson; William J Kennedy; Rajendra N Damle; Xiao-Jie Yan; Piers E M Patten; Saul Teichberg; Prasad Koduru; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  Autoimmunity and the risk of myeloproliferative neoplasms.

Authors:  Sigurdur Y Kristinsson; Ola Landgren; Jan Samuelsson; Magnus Björkholm; Lynn R Goldin
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

3.  Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results.

Authors:  O E Akwari; K M Itani; R E Coleman; W F Rosse
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

Review 4.  Surgical treatment of immune thrombocytopenic purpura.

Authors:  P Chirletti; M Cardi; P Barillari; A Vitale; P Sammartino; A Bolognese; R Caiazzo; M Ricci; I A Muttillo; V Stipa
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.